To explore whether RPL31, HIST1H2BD, and ADAMTS1 expression levels were altered in clinical prostate cancer samples, we assessed the expression status of these genes based on the ONCOMINE microarray dataset [30]. This evidence concerns the gene H2BC5 and Familial prostate cancer.